Drawing for PATIENTPASS

USPTO serial 88591036

PATIENTPASS

Reviewed by CopyMark Law Group

Reg. 6555772Status 700Renewal
Filing date
Status date
Registration date
Nov 9, 2021
Examiner
CLARK, MICHAEL J.
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PATIENTPASS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julia C. Archer

Julia C. Archer ENNS & ARCHER LLP939 BURKE STREETWINSTON-SALEM, NC 27101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Platform as a service featuring a computer software platform for providing patient education materials and information in the fields of health, healthcare, wellness, medicine, diseases, treatments, lab tests and pharmaceuticals; platform as a service featuring a computer software platform for integrating health information and providing patient access to educational content in the fields of health, healthcare, wellness, medicine, diseases, treatments, lab tests and pharmaceuticals; platform as a service featuring a computer software platform for enabling the reporting and analysis of clinician and patient activity pertaining to patient educationACTIVEJun 1, 2021
044Providing medical and health information through a web-based patient education platform; Providing educational information about medicine, health and healthcareACTIVEJun 1, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 9, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 6, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 5, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 28, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 28, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 26, 2021IUAFUSE AMENDMENT FILED—
Aug 26, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 18, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 23, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 23, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 3, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 12, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 19, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 21, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 21, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 21, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Feb 21, 2020CNSLSUSPENSION LETTER WRITTEN—
Feb 6, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 5, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 5, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 22, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 22, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 22, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2019DOCKASSIGNED TO EXAMINER—
Sep 7, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 27, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance